Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
04/2012
04/03/2012CA2501690C Amended recombinant cells (arcs) for the production and delivery of antiviral agents, adjuvants and vaccine accelerants
04/03/2012CA2453115C Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
04/03/2012CA2379220C Structural protein of adeno-associated virus with modified antigenicity, its production and its use
04/03/2012CA2294981C Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
04/03/2012CA2294031E Self-emulsifying formulation for lipophilic compounds
03/2012
03/29/2012WO2012040532A1 Substituted oxadiazole compounds and their use as s1p1 agonists
03/29/2012WO2012039518A1 Pharmaceutical composition for treatment and prevention of th3 march-related diseases
03/29/2012WO2012037612A1 Novel immunostimulatory method
03/29/2012WO2011152671A3 Pharmaceutical composition for the prevention or treatment of inflammatory diseases or immune diseases containing ramalin
03/29/2012WO2011112070A3 A composition to boost and enhance immune system and method of preparing thereof
03/29/2012US20120077857 Inhibition of inflammation bysimultaneous blockade of multiple prostanoid receptors
03/29/2012US20120077856 Pharmaceutical product
03/29/2012US20120077855 Crystalline tripeptide epoxy ketone protease inhibitors
03/29/2012US20120077838 Beta-2-Adrenoreceptor Agonists
03/29/2012US20120077830 Caspase inhibitors and uses thereof
03/29/2012US20120077827 Zap-70 active compounds
03/29/2012US20120077815 Fused Pyridine And Pyrazine Derivatives As Kinase Inhibitors
03/29/2012US20120077805 Unsolvated benzodiazepine compositions and methods
03/29/2012US20120077798 Azetidine and cyclobutane derivatives as jak inhibitors
03/29/2012US20120077785 Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis
03/29/2012US20120077775 Macrocyclic compounds useful as inhibitors of kinases and hsp90
03/29/2012US20120077754 Copolymer-1 improvements in compositions of copolymers
03/29/2012US20120077747 Fish-derived protein lysate, and uses thereof as immunomodulatory and/or anti-inflammatory agent
03/29/2012US20120077733 Antagonists against interaction of pf4 and rantes
03/29/2012US20120077732 Cyclic peptides and uses thereof
03/29/2012US20120077731 Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
03/29/2012US20120076831 Compositions and methods for induction of antigen-specific tolerance
03/29/2012US20120076829 Isolation, identification and characterisation of strains with probiotic activity, from faeces of infants fed exclusively with breast milk
03/29/2012US20120076827 Compositions and methods for generating an immune response in a subject
03/29/2012US20120076826 Recombinantly Produced Allergens
03/29/2012US20120076825 Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof
03/29/2012US20120076823 Vector
03/29/2012US20120076822 Influenza vaccines with reduced amounts of squalene
03/29/2012US20120076821 Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses
03/29/2012US20120076820 Cd40l vaccines, compositions, and methods related thereto
03/29/2012US20120076819 Compositions And Methods For Treating of Microbial Infections
03/29/2012US20120076817 Polysaccharide-protein conjugate vaccines
03/29/2012US20120076816 Novel malaria vaccine
03/29/2012US20120076815 Identification and characterization of racemases, definition of protein signatures, and a test for detecting d-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
03/29/2012US20120076814 Combinations of pneumococcal rrgb clades
03/29/2012US20120076813 USES OF GLUTAMYL tRNA SYNTHETASE (GtS) FRAGMENTS
03/29/2012US20120076810 Vaccinia virus polypeptides
03/29/2012US20120076809 Method to inhibit the biological activity of calcineurin with selective peptides
03/29/2012US20120076808 Combined antigen and dna vaccine for preventing and treating autoimmune diseases
03/29/2012US20120076807 Plasmids with immunological action
03/29/2012US20120076806 Chloramphenicol Acetyl Transferase (CAT)-Defective Somatostatin Fusion Protein And Uses Thereof
03/29/2012US20120076805 Methods and Compositions for the Generation and Maintenance of Regulatory T Cells
03/29/2012US20120076792 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
03/29/2012US20120076789 Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer
03/29/2012US20120076783 Reduced-viscosity concentrated protein formulations
03/29/2012US20120076774 Detection and/or treatment of diseases associated with autoantibodies
03/29/2012US20120076773 Novel Drug Delivery Devices
03/29/2012US20120076761 Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including Parkinson's disease
03/29/2012US20120076755 Hepatitis C Virus Inhibitors
03/29/2012US20120076753 Use of nkp46 for preventing diabetes
03/29/2012US20120076752 Mesothelin Vaccines and Model Systems
03/29/2012US20120076742 Topical drug delivery system with dual carriers
03/29/2012US20120076739 Novel combination of anticholinergics-b2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases
03/29/2012US20120076735 Nanoparticles for Extravascular Administration
03/29/2012US20120076730 Peptides for transport of therapeutics and their carriers in mouse models and humans
03/29/2012US20120076722 Methods for treating cancers and diseases associated with 4-1bb (cd137) expression
03/29/2012DE102010046837A1 Phenylchinazolinderivate Phenylchinazolinderivate
03/29/2012CA2812416A1 Human b1 cells and uses thereof
03/29/2012CA2812096A1 Oncolytic adenoviral vectors and methods and uses related thereto
03/29/2012CA2811957A1 Novel immunostimulatory method
03/29/2012CA2811023A1 Influenza treatment and/or characterization; human-adapted ha polypeptides; vaccines
03/28/2012EP2433943A1 Thienopyrazole derivatives having PDE7 inhibitory activity
03/28/2012EP2433650A2 Administration of anti-CD3 antibodies in the treatment of autoimmune diseases
03/28/2012EP2433639A2 Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy
03/28/2012EP2432784A1 Fused bicyclic pyrazole derivatives as kinase inhibitors
03/28/2012EP2432485A1 Prebiotic composition
03/28/2012EP2432461A1 Opioid receptors stimulating compounds (thymoquinone, nigella sativa) and food allergy
03/28/2012EP2252612B1 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors
03/28/2012EP2148862B1 Dihydroquinone and dihydronaphthridine inhibitors of jnk
03/28/2012EP2062968B1 Bacterial strain having anti-allergic activity, and beverage, food and anti-allergic agent comprising cell of the bacterial strain
03/28/2012EP1951233B1 Pirfenidone/toll-like receptor (tlr) agonist compositions and methods for using them to stimulate production of granulocyte colonizing stimulating factor (g-csf)
03/28/2012EP1308438B9 3-substituted urea derivatives and medicinal use thereof
03/28/2012EP1098909B1 Hybrid human/rodent igg antibody to cd3, and methods of its construction
03/28/2012CN1668287B Use of 3-deoxyflavonoids in preparing medicine for inhibition of t-lymphocyte activation
03/28/2012CN1635901B Remodeling and glycoconjugation of peptides
03/28/2012CN102395589A Fused pyrrolopyridine derivative
03/28/2012CN102391371A Protein for diagnosing and treating allergic disease and preparation method thereof
03/28/2012CN102391349A New honeysuckle lonimacranthoide and preparation method and application thereof
03/28/2012CN102391346A Oleanane saponin compounds and purpose thereof
03/28/2012CN102391251A Chemokine receptor antagonists
03/28/2012CN102391225A Mycophenolic acid derivatives Penicacids A, B, C and their application in preparing immunosuppression medicaments
03/28/2012CN102389427A Solid oral preparation containing rosiglitazone and cetirizine hydrochloride
03/28/2012CN102389423A Medicinal composition containing ibuprofen sodium salt
03/28/2012CN102389405A Tripterine oral self-emulsification dispersible tablet and its preparation method
03/28/2012CN102389404A Desloratadine medicament compound
03/28/2012CN102389385A Herba portulacae extract and solution, and preparation method and application
03/28/2012CN102389245A Formula of health care medicine pillow for detoxifying and health-promoting
03/28/2012CN102038703B New use of microRNA
03/28/2012CN102028757B Processing method of mulberry composite extract
03/28/2012CN101987162B Traditional Chinese medical preparation for treating anaphylatic purpura nephritis nephrotic syndrome
03/28/2012CN101973925B 2-indolone compound with anti-inflammatory activity, preparation method and medicinal application thereof
03/28/2012CN101914473B Lactic acid bacterium having immunoregulatory activity derived from moromi for wine fermentation
03/28/2012CN101757453B American ginseng-glossy ganoderma-dendrobe preparation and preparation method thereof
03/28/2012CN101676303B Low-molecular-weight glucan, its preparation method and use
03/28/2012CN101646654B Indozalyl sulphonamide derivatives useful as glucocorticoid modulators
1 ... 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 ... 1172